海尔生物：公司已将业务覆盖至全球150多个国家和地区，实现了18个国家的本地化部署

Core Viewpoint - Haier Biomedical aims to replicate the successful overseas acquisition strategy of Haier Smart Home in the medical device industry, focusing on high-potential sectors and global expansion [2]. Group 1: Company Strategy - Haier Biomedical, a subsidiary of Haier Group, is focused on becoming a world-class brand in life sciences, with operations in over 150 countries and regions [2]. - The company has achieved localized deployment in 18 countries, with overseas market revenue accounting for over 35% of total income [2]. Group 2: Future Plans - Haier Biomedical will continue to seek high-quality targets in the life sciences industry to enhance its existing business and expand its operational boundaries [2]. - The company emphasizes compliance with legal regulations and timely information disclosure as part of its strategic approach [2].